Cover Image

Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report

Transcatheter arterial chemoembolization (TACE) is one of the most common treatment options for patients with unresectable hepatocellular carcinoma (HCC). HCC rupture following TACE is a rare but potentially life-threatening complication. This report described a patient who experienced HCC rupture a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hye Hyeon Moon (Author), Hee Ho Chu (Author), Ji Hoon Shin (Author)
Format:	Book
Published:	Society of Gastrointestinal Intervention, 2021-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biliary complications after transcatheter arterial chemoembolization for hepatocellular carcinoma
by: Yoon Suk Lee, et al.
Published: (2020)

Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma
by: Ya-Qing Zhang MM, et al.
Published: (2017)

Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma
by: Ya-Qing Zhang MM, et al.
Published: (2017)

Cure of Hepatoblastoma Through Transcatheter Arterial Chemoembolization
by: Tianyou Yang, et al.
Published: (2017)

The update on transcatheter arterial chemoembolization using drug-eluting beads: Optimization for best response
by: Jung Suk Oh, et al.
Published: (2021)

Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model
by: Xueying Zhang, et al.
Published: (2024)

Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association
by: Yuri Cho, et al.
Published: (2023)

Outcome of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
by: Hadeel A Helmi, et al.
Published: (2020)

Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in the Downstaging of Intermediate-Stage Hepatocellular Carcinoma (HCC) in Patients With a Child-Pugh Score of 8-9
by: Roberto Minici, et al.
Published: (2021)

Safety and Efficacy of Degradable Starch Microspheres Transcatheter Arterial Chemoembolization as a Bridging Therapy in Patients with Early Stage Hepatocellular Carcinoma and Child-Pugh Stage B Eligible for Liver Transplant
by: Roberto Minici, et al.
Published: (2021)

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
by: Jiwon Yang, et al.
Published: (2024)

Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy
by: Byeong Geun Song, et al.
Published: (2024)

Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal
by: Degang Kong, et al.
Published: (2020)

Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma
by: Zizhuo Wang, et al.
Published: (2024)

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients
by: Juanfang Liu, et al.
Published: (2021)

Transarterial Chemoembolization Combined with Sorafenib in Patients with BCLC Stage C Hepatocellular Carcinoma
by: Liu KC, et al.
Published: (2020)

Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization
by: Li Q, et al.
Published: (2018)

Recent technical advances in conventional transarterial chemoembolization for hepatocellular carcinoma in Japan
by: Hiroki Higashihara, et al.
Published: (2021)

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles
by: Toshiyuki Irie, et al.
Published: (2020)

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma
by: Chiu SH, et al.
Published: (2020)

Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis
by: Zhao Q, et al.
Published: (2016)

Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019)

Efficacy of Selective Internal Radiation Therapy for Hepatocellular Carcinoma Post-Incomplete Response to Chemoembolization
by: Salma Binzaqr, et al.
Published: (2023)

Regorafenib-loaded poly (lactide-co-glycolide) microspheres designed to improve transarterial chemoembolization therapy for hepatocellular carcinoma
by: Xiang Li, et al.
Published: (2020)

Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population
by: Shuzhao Jia, et al.
Published: (2020)

Cost-effectiveness analysis of drug-eluting beads and conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Guoliang Shao, et al.
Published: (2022)

Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis
by: Tian X, et al.
Published: (2015)

The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
by: Zeng J, et al.
Published: (2023)

Outcomes of conventional transarterial chemoembolization using guidance software for hepatocellular carcinoma in the caudate lobe of the liver
by: Shiro Miyayama, et al.
Published: (2023)

Spontaneous rupture of hepatocellular carcinoma in children
by: Nejmeddine Affes, et al.
Published: (2010)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
by: Su Jong Yu, et al.
Published: (2023)

Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
by: Sujin Jin, et al.
Published: (2023)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
by: Won-Gyom Choe, et al.
Published: (2018)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
by: Won-Gyom Choe, et al.
Published: (2018)

Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma
by: Ying He, et al.
Published: (2023)

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma
by: Zhong JH, et al.
Published: (2015)

Safety and Efficacy of Liver Venous Deprivation Following Transarterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma
by: Sy TV, et al.
Published: (2023)

Chinese herbal medicine, Jianpi Ligan decoction, improves prognosis of unresectable hepatocellular carcinoma after transarterial chemoembolization: a retrospective study
by: Tang CW, et al.
Published: (2016)

Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients With Large Unresectable Hepatocellular Carcinoma
by: Haixia Zhang, et al.
Published: (2022)

Hemoperitoneum Caused by Spontaneous Rupture of Hepatocellular Carcinoma
by: Nata P Hardjo Lugito, et al.
Published: (2015)